You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
匯盈控股(00821.HK):訂立分許可協議
格隆匯 12-17 19:15

格隆匯 12 月 17日丨匯盈控股(00821.HK)公佈,Vast Sea, LLC("Vast Sea")與Success Health Global Limited("被許可人")(公司附屬公司)於2020年7月17日訂立許可協議,據此,Vast Sea根據並按照許可協議的條文向被許可人授出專利的獨家許可。

於2020年12月17日,Vast Sea Biotechnology, Inc.(Vast Sea的權益承繼人)(與Vast Sea均可稱"許可人")、被許可人 及Hopkins BiotechCompany(一間於美利堅合眾國註冊成立的公司)("分被許可人")(統稱"訂約方")訂立分許可協議,據此,被許可人將該許可所涉之若干相關程序分授予分被許可人("分許可事項")。

分被許可人須就相關產品向被許可人支付專利權費,有關專利費金額將相當於分被許可人出售相關產品之售價之5%

公告稱,分被許可人就相關產品所獲得之分許可權將容許分被許可人於美國及分許可地區製造及生產相關產品,並於分許可地區內推銷及銷售相關產品。透過收取專利費,分許可協議可確保穩定而持續之收益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account